×
Newsmax TV & Webwww.newsmax.comFREE - In Google Play
VIEW
×
Newsmax TV & Webwww.newsmax.comFREE - On the App Store
VIEW
Tags: elon musk | twitter | poison pill

Musk, Twitter Talks Still Possible

Musk
Elon Musk (Getty Images)

Monday, 18 April 2022 03:10 PM EDT

Twitter has dropped a major roadblock in front of Elon Musk’s effort to take over the company, leaving investors to wonder about the mercurial Tesla CEO’s next move.

The social media company has adopted a “poison pill” defense that makes it difficult for Musk or any other investor to buy Twitter without the board of directors’ approval. Musk, who currently owns about 9% of the company, last week disclosed an offer of about $43 billion, or $54.20 per share.

Twitter’s next likely move is to formally reject Musk’s offer, although it could also enter into negotiations. Musk has a number of options which also include talks with the board, sweetening his offer, or even triggering the poison pill, which experts say could be disastrous for the company.

In a regulatory filing on Monday, Twitter’s board said it approved the defensive move to protect the social media platform from “coercive or otherwise unfair” takeover tactics.

Talks Still on the Table

The board is still leaving open the possibility of negotiating with Musk or another suitor. The filing says the shareholder rights agreement should not interfere with any merger, offer or other business combination approved by the board.

Although he said his offer was “final,” Musk may have to raise his bid to satisfy other shareholders. A Saudi prince who is among Twitter’s major shareholders scoffed at Musk’s offer last week in a tweet. Al Waleed bin Talal said he would reject the overtures because he didn’t believe $43 billion “comes close to the intrinsic value of Twitter, given its growth prospects.” Twitter shares hit an all-time high of $77.63 in March 2021.

When he made his offer public, Musk provided no details on financing, but such a disclosure could improve his chances. He could raise some of the money by borrowing billions using his stakes in Tesla and SpaceX as collateral, and he could bring in other investors.

The Twitter board's poison pill would give stockholders as of April 25 the right to buy one one-thousandth of a share of preferred stock for each common share they own, at a price of $210. The rights are triggered if any person or group of investors buys 15% or more of the company’s shares without board approval.

The preferred stock would have the same voting rights as a common share, according to the filing, which does not specifically mention Musk.

No Investor Has Swallowed a Poison Pill

The poison pill defense essentially would spell the end of Twitter if Musk or another investor acquires 15% or more of the company, said James Cox, a professor of corporate and securities law at Duke University.

Shareholders who exercise the rights and buy preferred stock at $210 would get $420 in Twitter stock or assets, he said. That would be more than Twitter can afford to pay, and likely would send the company into receivership, Cox said.

“You want to create an event that Musk would never want to trigger because it would be the death of Twitter,” Cox said. He predicts that Musk and the board will negotiate, at least for a while, adding that no investor has ever crossed the line to activate a poison pill.

If Musk went ahead and triggered the poison pill, he risks wiping out much of the money he has invested in Twitter because his stake would be diluted, said Columbia University law professor Eric Talley. “You want to deter someone from deliberately triggering the poison pill,” Talley said.

Twitter's board has a lot of information that the average shareholder doesn't, such as future earnings or market growth projections, and whether there's reason to believe that the share value is artificially depressed, Talley said. The board, he said, could just hold out.

"They’re sitting right now on top of a poison pill that’s a bit of a showstopper. From a corporate law perspective, they’re on pretty solid footing right now if they just keep that in place and say they’re not comfortable bargaining at this stage.”

Musk said in making his bid that Twitter “needs to be transformed as a private company” in order to build trust with its users and do better at serving what he calls the “societal imperative” of free speech. He said shareholders, not the board, should decide whether Twitter goes private.

Shares $7 Below Musk's Offer

Shares of Twitter rose 3.6% to $46.72 in Monday afternoon trading, still $7.48 shy of Musk’s offer. That’s a sign that investors are skeptical of whether Musk can pull off the deal.

Musk began accumulating Twitter shares in late January, ending up with a stake of about 9%. Only Vanguard Group controls more Twitter shares. A lawsuit filed last week in New York federal court alleged Musk illegally delayed disclosing his stake so he could buy more shares at lower prices.

Musk took to Twitter to criticize board members in recent days, saying he’d save about $3 million per year by bringing the board salary to zero if his bid succeeds, and noting that board members collectively owning just a tiny financial stake in Twitter shows that their “economic interests are simply not aligned with shareholders.”

He also used an exclamation point to express surprise that one board member, Robert Zoellick, a former World Bank president, doesn’t appear to have ever posted anything from his profile on the social media site. Musk, who has more than 82 million followers, is a prolific tweeter who has criticized other celebrity accounts for not tweeting enough, suggesting that as a sign that Twitter is dying.

Related stories:

© Copyright 2024 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.


StreetTalk
Twitter has dropped a major roadblock in front of Elon Musk's effort to take over the company, leaving investors to wonder about the mercurial Tesla CEO's next move.
elon musk, twitter, poison pill
953
2022-10-18
Monday, 18 April 2022 03:10 PM
Newsmax Media, Inc.

Sign up for Newsmax’s Daily Newsletter

Receive breaking news and original analysis - sent right to your inbox.

(Optional for Local News)
Privacy: We never share your email address.
Join the Newsmax Community
Read and Post Comments
Please review Community Guidelines before posting a comment.
 
Get Newsmax Text Alerts
TOP

Newsmax, Moneynews, Newsmax Health, and Independent. American. are registered trademarks of Newsmax Media, Inc. Newsmax TV, and Newsmax World are trademarks of Newsmax Media, Inc.

NEWSMAX.COM
MONEYNEWS.COM
© Newsmax Media, Inc.
All Rights Reserved
NEWSMAX.COM
MONEYNEWS.COM
© Newsmax Media, Inc.
All Rights Reserved